TOCILIZUMAB, Placebo of Tocilizumab
APHP191062
Phase 3 small_molecule active
Quick answer
TOCILIZUMAB, Placebo of Tocilizumab for Giant cell arteritis with Cerebro-vascular involvement is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Giant cell arteritis with Cerebro-vascular involvement
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active